[15 years experience in treating chronic myeloleukemia patients at a polyclinic].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000553:Ambulatory Care; D000970:Antineoplastic Agents / Q000008:administration & dosage; D001388:Aziridines / Q000008:administration & dosage; D001772:Blood Cell Count; D002066:Busulfan / Q000008:administration & dosage; D004341:Drug Evaluation; D004351:Drug Resistance; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D008927:Mitobronitol / Q000008:administration & dosage; D009946:Organothiophosphorus Compounds / Q000008:administration & dosage; D013997:Time Factors
D000970:Antineoplastic Agents; D001388:Aziridines; D009946:Organothiophosphorus Compounds; C013556:hexaphosphamide; D008927:Mitobronitol; D002066:Busulfan
Piatnadtsatiletniĭ opyt lecheniia bol'nykh khronicheskim mieloleĭkozom v poliklinicheskikh usloviiakh.